ACADIAN ASSET MANAGEMENT LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 114 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q4 2022$74
-99.9%
129,212
+212.9%
0.00%
-100.0%
Q2 2021$144,000
+65.5%
41,300
+158.8%
0.00%
Q3 2019$87,000
-70.9%
15,956
-36.5%
0.00%
-100.0%
Q2 2019$299,000
+464.2%
25,143
+148.4%
0.00%
Q1 2019$53,000
-81.9%
10,122
-80.0%
0.00%
-100.0%
Q1 2018$293,00050,6030.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2021
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders